Showing results (11-20 of 48) with videos related to
Sort By:
Pageof 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2007
Reduced dose intensity of docetaxel plus capecitabine as second-line palliative chemotherapy in patients with metastatic gastric cancer: a phase II studyG Rosati, D Bilancia, D Germano, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2009
Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomized phase II studyG Rosati, S Cordio, R Bordonaro, et al.JAMA Otolaryngology-- Head & Neck Surgery|April 28, 2022
Association of a Multimodal Intervention With Decreased Opioid Prescribing After Neck Dissection for Malignant Thyroid Disease With Short Hospital StayJennifer P March, James Y Lim, Katherine L Manzione, et al.The Journal of Urology|June 7, 2000
Gemcitabine plus cisplatin for advanced transitional cell carcinoma of the urinary tract: a phase II multicenter trialV Lorusso, L Manzione, F De Vita, et al.Il Giornale Di Chirurgia|June 12, 2008
[Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery]F Scutari, G Tramutola, A Morlino, et al.Minerva Ginecologica|March 1, 1993
[Primary malignant melanoma of the vagina]A M Lomeo, G Iacobellis, G Martoccia, et al.Oncology|January 11, 2001
Topotecan and gemcitabine in platinum/paclitaxel-resistant ovarian cancerS Greggi, M G Salerno, G D'Agostino, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2005
Weekly paclitaxel plus capecitabine in advanced breast cancer patients: dose-finding trial of GOIRC and GOLF Di Costanzo, S Gasperoni, P Papaldo, et al.Minerva Ginecologica|March 1, 1992
[Vulvar papillary hidrocystadenoma. Description of a case]A M Lomeo, L Manzione, G Martoccia, et al.Journal of Chemotherapy (Florence, Italy)|December 13, 2007
Phase II trial of a biweekly regimen of fluorouracil and leucovorin plus irinotecan in patients with previously untreated advanced gastric cancerG Rosati, S Cordio, G Caputo, et al.Pageof 5